Literature DB >> 3573821

Flow cytometric DNA patterns from colorectal cancers--how reproducible are they?

N A Scott, J P Grande, L H Weiland, J H Pemberton, R W Beart, M M Lieber.   

Abstract

The heterogeneity of DNA ploidy patterns within individual colorectal carcinomas was investigated by analyzing 261 different samples from 30 fresh colorectal cancers. The results of DNA analysis of multiple superficial cup biopsy specimens, of multiple full-thickness fresh tumor slices, and of nuclei extracted from paraffin-embedded pathologic archival specimens with use of the Hedley technique were compared. The same DNA ploidy pattern was found in all specimens of 19 (63%) of the 30 tumors studied. Minimal heterogeneity for DNA ploidy pattern was noted in seven carcinomas (23%), and moderate to marked heterogeneity was found in an additional four tumors (13%). The DNA pattern of a full-thickness specimen from 79% of the carcinomas studied was the same when samples were obtained from any one of five possible sites. In addition, the DNA ploidy pattern of the majority of the carcinomas could have been accurately predicted by flow cytometric DNA analysis of superficial cup biopsy specimens. These results demonstrate that most colorectal carcinomas are DNA ploidy homogeneous. Therefore, measurement of this tumor property can be used in future clinical research studies with some degree of confidence.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3573821     DOI: 10.1016/s0025-6196(12)65435-4

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  8 in total

Review 1.  The prognostic value of flow cytometric DNA analysis in colorectal cancer patients.

Authors:  H Suzuki
Journal:  Jpn J Surg       Date:  1988-09

2.  Clinical importance of DNA content in rectal cancer measured by flow cytometry.

Authors:  J R Jass; K Mukawa; H S Goh; S B Love; D Capellaro
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

3.  Prognostic significance of tumor markers in colorectal cancer patients: DNA index, S-phase fraction, p53 expression, and Ki-67 index.

Authors:  Y T Chen; M J Henk; K J Carney; W D Wong; D A Rothenberger; T Zheng; M Feygin; R D Madoff
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

4.  The prognostic role of the DNA ploidy pattern in colorectal cancer analysis using paraffin-embedded tissue by an improved method.

Authors:  Y Yamazoe; S Maetani; T Nishikawa; H Onodera; T Tobe; M Imamura
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

5.  Sex hormone-receptor-negative tumors have a higher proliferative activity than sex hormone-receptor-positive tumors in human adenocarcinomas of the gastrointestinal tract.

Authors:  D Korenaga; H Orita; T Okuyama; J Kinoshita; S Maekawa; T Ikeda; K Sugimachi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

6.  Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.

Authors:  R Palmqvist; A Oberg; C Bergström; J N Rutegård; B Zackrisson; R Stenling
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

7.  Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer.

Authors:  M S Wilson; C M West; G D Wilson; S A Roberts; R D James; P F Schofield
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

8.  Detection of the growth fraction in colorectal tumours by a monoclonal antibody against DNA polymerase alpha.

Authors:  A Yamaguchi; S Takegawa; T Ishida; G Nishimura; M Kato; M Kanno; T Kosaka; Y Yonemura; I Miyazaki
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.